September 16, 2025 · Form 4 insider transaction
Biofrontera AG bought 3,019 shares of Biofrontera Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
The reporting person acquired the convertible preferred stock in a privately negotiated transaction in exchange for assets related to the production and sale of certain products in the United States having an estimated market value of approximately $3,019,000.; The convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date.